Zealous Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 1.13 Cr
as on 05-07-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 53.50 Cr
as on 05-07-2024
- Revenue 163.52%
(FY 2022)
- Profit 275.67%
(FY 2022)
- Ebitda -161.71%
(FY 2022)
- Net Worth 2.23%
(FY 2022)
- Total Assets 73.88%
(FY 2022)
About Zealous Biotechnologies
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.13 Cr.
The company currently has active open charges totaling ₹53.50 Cr.
Parvesh Jain, Deepesh Jain, and Reetesh Jain serve as directors at the Company.
- CIN/LLPIN
U24232UP2005PTC030508
- Company No.
030508
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Zealous Biotechnologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parvesh Jain  | Director | 01-Oct-2011 | Current |
| Deepesh Jain | Director | 01-Oct-2011 | Current |
| Reetesh Jain | Director | 01-Oct-2011 | Current |
Financial Performance and Corporate Structure Insights of Zealous Biotechnologies.
Zealous Biotechnologies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 163.52% increase. The company also saw a substantial improvement in profitability, with a 275.67% increase in profit. The company's net worth moved up by a moderate rise of 2.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zealous Biotechnologies?
Unlock access to Zealous Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_LIMITED.webp)
Arihant Publications (India) LimitedActive 20 years 7 monthsParvesh Jain, Deepesh Jain and 1 more are mutual person
Arihant Edu Web Private LimitedActive 15 years 3 monthsDeepesh Jain and Reetesh Jain are mutual person
Bloomcap Edu Ventures Private LimitedActive 7 years 2 monthsParvesh Jain, Deepesh Jain and 1 more are mutual person
_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 May 2014 | ₹53.50 Cr | Open |
How Many Employees Work at Zealous Biotechnologies?
Unlock and access historical data on people associated with Zealous Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zealous Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zealous Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
